Abstract
The 44th Annual Congress of the International Society of Oncology and Biomarkers took place in Rio de Janeiro, Brazil between September 7 and 10, 2017 (http://isobm2017.com/) with the subtitle: "Biomarkers in oncology: new horizons and challenges in the diagnosis and treatment of cancer". The program offered topics regarding discovery, validation, evaluation, and use of tumor biomarkers currently used in the whole process of patient's care from prevention, prediction, early diagnosis, through treatment, treatment monitoring and follow up monitoring.
The presentations were split into the key note lectures, oral presentations, poster presentations, and satellite symposiums. The congress offered participants the opportunity to link clinical and research oncologists to discuss new tools for diagnosis and monitoring of cancer diseases.